Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Corindus Vascular Robotics Inc stock logo
CVRS
Corindus Vascular Robotics
$4.27
$4.27
$0.78
$4.40
$891.09MN/A1.99 million shsN/A
LivaNova PLC stock logo
LIVN
LivaNova
$56.52
-3.7%
$49.41
$32.48
$58.91
$3.21B0.97609,093 shs468,405 shs
Envista Holdings Corporation stock logo
NVST
Envista
$20.76
-0.3%
$20.50
$14.22
$23.00
$3.46B0.991.55 million shs1.76 million shs
TransMedics Group, Inc. stock logo
TMDX
TransMedics Group
$107.79
-0.5%
$116.66
$55.00
$169.29
$3.69B2.18893,808 shs1.04 million shs
Beginner's Guide To Retirement Stocks Cover

Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Corindus Vascular Robotics Inc stock logo
CVRS
Corindus Vascular Robotics
0.00%0.00%0.00%0.00%0.00%
LivaNova PLC stock logo
LIVN
LivaNova
-3.75%-0.12%+14.04%+21.21%+20.28%
Envista Holdings Corporation stock logo
NVST
Envista
-0.36%+2.21%+2.82%+9.99%+20.39%
TransMedics Group, Inc. stock logo
TMDX
TransMedics Group
-0.45%+0.79%-15.30%-24.64%-20.56%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Corindus Vascular Robotics Inc stock logo
CVRS
Corindus Vascular Robotics
$4.27
$4.27
$0.78
$4.40
$891.09MN/A1.99 million shsN/A
LivaNova PLC stock logo
LIVN
LivaNova
$56.52
-3.7%
$49.41
$32.48
$58.91
$3.21B0.97609,093 shs468,405 shs
Envista Holdings Corporation stock logo
NVST
Envista
$20.76
-0.3%
$20.50
$14.22
$23.00
$3.46B0.991.55 million shs1.76 million shs
TransMedics Group, Inc. stock logo
TMDX
TransMedics Group
$107.79
-0.5%
$116.66
$55.00
$169.29
$3.69B2.18893,808 shs1.04 million shs
Beginner's Guide To Retirement Stocks Cover

Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Corindus Vascular Robotics Inc stock logo
CVRS
Corindus Vascular Robotics
0.00%0.00%0.00%0.00%0.00%
LivaNova PLC stock logo
LIVN
LivaNova
-3.75%-0.12%+14.04%+21.21%+20.28%
Envista Holdings Corporation stock logo
NVST
Envista
-0.36%+2.21%+2.82%+9.99%+20.39%
TransMedics Group, Inc. stock logo
TMDX
TransMedics Group
-0.45%+0.79%-15.30%-24.64%-20.56%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Corindus Vascular Robotics Inc stock logo
CVRS
Corindus Vascular Robotics
0.00
N/AN/AN/A
LivaNova PLC stock logo
LIVN
LivaNova
3.00
Buy$59.715.65% Upside
Envista Holdings Corporation stock logo
NVST
Envista
2.33
Hold$20.920.81% Upside
TransMedics Group, Inc. stock logo
TMDX
TransMedics Group
2.70
Moderate Buy$122.1113.29% Upside

Current Analyst Ratings Breakdown

Latest CVRS, TMDX, NVST, and LIVN Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
9/4/2025
TransMedics Group, Inc. stock logo
TMDX
TransMedics Group
Stifel Nicolaus
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Initiated CoverageHold$115.00
9/3/2025
LivaNova PLC stock logo
LIVN
LivaNova
Needham & Company LLC
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingBuy$64.00
8/25/2025
TransMedics Group, Inc. stock logo
TMDX
TransMedics Group
Needham & Company LLC
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingHold
8/21/2025
LivaNova PLC stock logo
LIVN
LivaNova
Barclays
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetEqual Weight$55.00 ➝ $58.00
8/1/2025
Envista Holdings Corporation stock logo
NVST
Envista
Stifel Nicolaus
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetBuy$24.00 ➝ $25.00
8/1/2025
Envista Holdings Corporation stock logo
NVST
Envista
Mizuho
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetUnderperform$15.00 ➝ $18.00
8/1/2025
Envista Holdings Corporation stock logo
NVST
Envista
Wells Fargo & Company
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetEqual Weight$17.00 ➝ $19.00
8/1/2025
Envista Holdings Corporation stock logo
NVST
Envista
Morgan Stanley
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetEqual Weight$16.00 ➝ $17.00
8/1/2025
Envista Holdings Corporation stock logo
NVST
Envista
Piper Sandler
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetNeutral$17.00 ➝ $19.00
8/1/2025
TransMedics Group, Inc. stock logo
TMDX
TransMedics Group
Morgan Stanley
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetEqual Weight$115.00 ➝ $123.00
7/29/2025
Envista Holdings Corporation stock logo
NVST
Envista
UBS Group
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetNeutral$18.00 ➝ $22.00
(Data available from 9/11/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Corindus Vascular Robotics Inc stock logo
CVRS
Corindus Vascular Robotics
N/AN/AN/AN/AN/AN/A
LivaNova PLC stock logo
LIVN
LivaNova
$1.25B2.46$4.08 per share13.85$24.31 per share2.32
Envista Holdings Corporation stock logo
NVST
Envista
$2.51B1.37$1.66 per share12.53$17.05 per share1.22
TransMedics Group, Inc. stock logo
TMDX
TransMedics Group
$441.54M8.32$1.64 per share65.81$6.81 per share15.83
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Corindus Vascular Robotics Inc stock logo
CVRS
Corindus Vascular Robotics
N/AN/A0.00N/AN/AN/AN/AN/A
LivaNova PLC stock logo
LIVN
LivaNova
$63.23M-$3.89N/A18.00N/A-16.13%14.57%6.91%10/29/2025 (Estimated)
Envista Holdings Corporation stock logo
NVST
Envista
-$1.12B$0.3264.8617.151.112.11%4.84%2.68%10/29/2025 (Estimated)
TransMedics Group, Inc. stock logo
TMDX
TransMedics Group
$35.46M$1.9355.8575.38N/A13.49%28.02%8.64%10/27/2025 (Estimated)

Latest CVRS, TMDX, NVST, and LIVN Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/6/2025Q2 2025
LivaNova PLC stock logo
LIVN
LivaNova
$0.84$1.05+$0.21$0.50$332.20 million$352.50 million
7/31/2025Q2 2025
Envista Holdings Corporation stock logo
NVST
Envista
$0.24$0.26+$0.02$0.16$638.21 million$682.10 million
7/30/2025Q2 2025
TransMedics Group, Inc. stock logo
TMDX
TransMedics Group
$0.48$0.92+$0.44$0.92$146.64 million$157.37 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Corindus Vascular Robotics Inc stock logo
CVRS
Corindus Vascular Robotics
N/AN/AN/AN/AN/A
LivaNova PLC stock logo
LIVN
LivaNova
N/AN/AN/AN/AN/A
Envista Holdings Corporation stock logo
NVST
Envista
N/AN/AN/AN/AN/A
TransMedics Group, Inc. stock logo
TMDX
TransMedics Group
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Corindus Vascular Robotics Inc stock logo
CVRS
Corindus Vascular Robotics
N/AN/AN/A
LivaNova PLC stock logo
LIVN
LivaNova
0.31
1.29
1.09
Envista Holdings Corporation stock logo
NVST
Envista
0.46
2.44
2.08
TransMedics Group, Inc. stock logo
TMDX
TransMedics Group
1.61
9.86
9.17

Institutional Ownership

CompanyInstitutional Ownership
Corindus Vascular Robotics Inc stock logo
CVRS
Corindus Vascular Robotics
N/A
LivaNova PLC stock logo
LIVN
LivaNova
97.64%
Envista Holdings Corporation stock logo
NVST
Envista
N/A
TransMedics Group, Inc. stock logo
TMDX
TransMedics Group
99.67%

Insider Ownership

CompanyInsider Ownership
Corindus Vascular Robotics Inc stock logo
CVRS
Corindus Vascular Robotics
N/A
LivaNova PLC stock logo
LIVN
LivaNova
0.29%
Envista Holdings Corporation stock logo
NVST
Envista
0.66%
TransMedics Group, Inc. stock logo
TMDX
TransMedics Group
7.00%
CompanyEmployeesShares OutstandingFree FloatOptionable
Corindus Vascular Robotics Inc stock logo
CVRS
Corindus Vascular Robotics
90208.69 millionN/ANot Optionable
LivaNova PLC stock logo
LIVN
LivaNova
2,90054.60 million54.44 millionOptionable
Envista Holdings Corporation stock logo
NVST
Envista
12,300166.18 million165.09 millionOptionable
TransMedics Group, Inc. stock logo
TMDX
TransMedics Group
21034.09 million31.70 millionOptionable

Recent News About These Companies

TransMedics Group (NASDAQ:TMDX) Coverage Initiated at Stifel Nicolaus
TransMedics: Just Like The CEO, I'm Buying

New MarketBeat Followers Over Time

Media Sentiment Over Time

Corindus Vascular Robotics stock logo

Corindus Vascular Robotics NYSEAMERICAN:CVRS

$4.27 0.00 (0.00%)
As of 11/27/2019

Corindus Vascular Robotics, Inc. designs, manufactures, and sells robotic-assisted systems for use in interventional vascular procedures in the United States and internationally. The company offers CorPath system, a medical device with robotic-assisted precision for coronary and peripheral interventional procedures. Its CorPath system allows the physician to perform procedures with a control console located within an interventional cockpit; and CorPath GRX system enables the precise robotic-assisted control of guide catheters, guidewires, and balloon/stent devices from the safety of a radiation-shielded interventional cockpit. The company sells its products through direct sales force, as well as through distributor and partnership relationships. It serves vascular, coronary, peripheral vascular, neurointerventional, and structural heart markets. Corindus Vascular Robotics, Inc. is headquartered in Waltham, Massachusetts.

LivaNova stock logo

LivaNova NASDAQ:LIVN

$56.52 -2.20 (-3.75%)
Closing price 09/10/2025 04:00 PM Eastern
Extended Trading
$56.52 0.00 (0.00%)
As of 09/10/2025 07:22 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. The company operates through Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support segments. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines, autotransfusion systems, perfusion tubing systems, cannulae, connect, and other related products. The Neuromodulation segment designs, develops, markets, and sells VNS Therapy System, an implantable pulse generator and connective lead that stimulates the vagus nerve; difficult-to-treat depression and drug-resistant epilepsy devices. The Advanced Circulatory Support segment develops, produces, and sells temporary life support products. It serves perfusionists, neurologists, neurosurgeons, and other physicians, as well as hospitals, other medical institutions, and healthcare providers. The company sells its products through direct sales representatives and independent distributors. LivaNova PLC was incorporated in 2015 and is headquartered in London, the United Kingdom.

Envista stock logo

Envista NYSE:NVST

$20.76 -0.06 (-0.26%)
Closing price 09/10/2025 03:59 PM Eastern
Extended Trading
$20.78 +0.02 (+0.10%)
As of 09/10/2025 07:23 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products. This segment also provides software packages, which include DTX Studio Implant; DTX Studio Lab; and DTX Studio Clinic, a software package offered with its imaging products. It offers its products under the Nobel Biocare, Alpha-Bio Tec, Implant Direct, Nobel Procera, Ormco, Spark, Orascoptic, Damon, Insignia, AOA brands. The Equipment & Consumables segment provides dental equipment and supplies, including digital imaging systems, software, and other visualization/magnification systems; endodontic systems and related products; restorative materials, rotary burs, impression materials, bonding agents, and cements; and infection prevention products. This segment offers its products under the Dexis, DTX Studio, Kerr, Metrex, Total Care, Pentron, Optibond, Harmonize, Sonicfill, Sybron Endo, and CaviWipes to dental offices, clinics, and hospitals. Envista Holdings Corporation was incorporated in 2018 and is headquartered in Brea, California.

TransMedics Group stock logo

TransMedics Group NASDAQ:TMDX

$107.79 -0.49 (-0.45%)
Closing price 09/10/2025 04:00 PM Eastern
Extended Trading
$107.69 -0.10 (-0.09%)
As of 09/10/2025 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and customized technology to replicate near-physiologic conditions for donor organs outside of the human body. Its OCS includes OCS LUNG for the preservation of standard criteria donor lungs for double-lung transplantation; OCS Heart, a technology for preservation of DBD donor hearts deemed unsuitable due to limitations of cold storage and for ex vivo reanimation, functional monitoring, and beating-heart preservation of donation-after-circulatory-death hearts; and OCS Liver for the preservation of DBD and DCD of donor livers. The company also developed national OCS program, a turnkey solution for outsourced organ retrieval; and provides OCS organ management and logistics services, including aviation and ground transportation, and other coordination activity. The company was founded in 1998 and is headquartered in Andover, Massachusetts.